Guillain-Barré syndrome: causes, immunopathogenic mechanisms and treatment
AK Jasti, C Selmi, JC Sarmiento-Monroy… - Expert review of …, 2016 - Taylor & Francis
ABSTRACT Introduction: Guillain-Barré syndrome is a rare disease representing the most
frequent cause of acute flaccid symmetrical weakness of the limbs and areflexia usually …
frequent cause of acute flaccid symmetrical weakness of the limbs and areflexia usually …
Guillain-Barré syndrome: epidemiology, pathophysiology and management
S Kuwabara - Drugs, 2004 - Springer
Guillain-Barré syndrome (GBS) is clinically defined as an acute peripheral neuropathy
causing limb weakness that progresses over a time period of days or, at the most, up to 4 …
causing limb weakness that progresses over a time period of days or, at the most, up to 4 …
Infectious and noninfectious triggers in Guillain–Barré syndrome
BR Wakerley, N Yuki - Expert review of clinical immunology, 2013 - Taylor & Francis
Guillain–Barré syndrome (GBS) is the commonest cause of acquired flaccid paralysis in the
world and regarded by many as the prototype for postinfectious autoimmunity. Here the …
world and regarded by many as the prototype for postinfectious autoimmunity. Here the …
Guillain–barré syndrome
S Esposito, MR Longo - Autoimmunity reviews, 2017 - Elsevier
Abstract The term Guillain–Barré syndrome (GBS), the most frequent cause of acute
paralytic neuropathy, covers a number of recognisably distinct variants. The exact cause of …
paralytic neuropathy, covers a number of recognisably distinct variants. The exact cause of …
Guillain-barré syndrome
AF Hahn - The lancet, 1998 - thelancet.com
Guillain-Barré syndrome (GBS) is viewed as a reactive, self-limited, autoimmune disease
triggered by a preceding bacterial or viral infection. Campylobacter jejuni, a major cause of …
triggered by a preceding bacterial or viral infection. Campylobacter jejuni, a major cause of …
Progress in Guillain-Barré syndrome
HP Hartung, BC Kieseier, R Kiefer - Current opinion in neurology, 2001 - journals.lww.com
This editorial review summarizes and critically analyses reports published in the preceding
18 months on the pathogenesis of Guillain-Barré syndrome, with particular emphasis on the …
18 months on the pathogenesis of Guillain-Barré syndrome, with particular emphasis on the …
[HTML][HTML] Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosis
B Van den Berg, C Walgaard, J Drenthen… - Nature Reviews …, 2014 - nature.com
Guillain–Barré syndrome (GBS) is a potentially life-threatening postinfectious disease
characterized by rapidly progressive, symmetrical weakness of the extremities. About 25% of …
characterized by rapidly progressive, symmetrical weakness of the extremities. About 25% of …
Guillain-Barré syndrome
U Seneviratne - Postgraduate medical journal, 2000 - academic.oup.com
Guillain-Barré syndrome is an autoimmune disorder encompassing a heterogeneous group
of pathological and clinical entities. Antecedent infections are thought to trigger an immune …
of pathological and clinical entities. Antecedent infections are thought to trigger an immune …
Guillain–Barré syndrome: Clinical variants and their pathogenesis
JB Winer - Journal of neuroimmunology, 2011 - Elsevier
Guillain–Barré syndrome: Clinical variants and their pathogenesis - ScienceDirect Skip to main
contentSkip to article Elsevier logo Journals & Books Search RegisterSign in View PDF …
contentSkip to article Elsevier logo Journals & Books Search RegisterSign in View PDF …
What's new in Guillain-Barré syndrome?
J Pritchard - Postgraduate medical journal, 2008 - academic.oup.com
Guillain-Barré syndrome (GBS) has become the major cause of acute neuromuscular
paralysis in the Western world since the eradication of polio, with an annual incidence of 1 …
paralysis in the Western world since the eradication of polio, with an annual incidence of 1 …